AFT rival gains FDA approval

5.4.21 AFT Pharmaceuticals does not expect that the FDA’s approval of a medicine developed by Japanese company Nobelpharma will affect the $12.5 million carrying value of the Pascomer assets in the company’s accounts. AFT managing Director Dr Hartley Atkinsion also confirmed that AFT retains its guidance for an operating profit for the year to 31 […]